Sector: Technology | Industry: Internet Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 2701 Olympic Boulevard, Suite 990 SANTA MONICA CA 90404 |
Tel: | N/A |
Website: | https://investors.goodrx.com |
IR: | See website |
Key People | ||
Trevor Bezdek Chairman of the Board, Co-Founder | Scott W. Wagner Interim Chief Executive Officer | Douglas Joseph Hirsch Co-Founder, Chief Mission Officer, Director |
Karsten Voermann Chief Financial Officer | Bansi J. Nagji President - Healthcare | Raj Beri Chief Operating Officer |
Andrew Slutsky Senior Vice President - Strategic Marketing Innovation , Chief Marketing Officer | Romin Nabiey Chief Accounting Officer |
Business Overview |
GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering. |
Financial Overview |
For the fiscal year ended 31 December 2023, Goodrx Holdings Inc revenues decreased 2% to $750.3M. Net loss decreased 73% to $8.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Advertising Expense decrease of 12% to $198.8M (expense), Acquisition Cost of Group Companies decrease of 93% to $1.8M (expense). |
Employees: | 694 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $2,789M as of Dec 31, 2023 |
Annual revenue (TTM): | $750.27M as of Dec 31, 2023 |
EBITDA (TTM): | $120.91M as of Dec 31, 2023 |
Net annual income (TTM): | -$8.87M as of Dec 31, 2023 |
Free cash flow (TTM): | $82.53M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 394,997,372 as of Feb 20, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |